| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |